The Glioma clinical trial analysis report delivers important insights into ongoing research on 180+ pipeline Glioma drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US), September 10, 2026- DelveInsight’s
The ANCA Vasculitis clinical trial analysis report delivers important insights into ongoing research of 12+ pipeline ANCA Vasculitis drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US) September 10,
The PH-ILD clinical trial analysis report delivers important insights into ongoing research on multiple pipeline PH-ILD drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US) September 10, 2026- DelveInsight’s
The Chronic Obstructive Pulmonary Disease clinical trial analysis report delivers important insights into ongoing research of 65+ pipeline Chronic Obstructive Pulmonary Disease drugs, clinical strategies, upcoming therapeutics, and commercial analysis.
The Key Eosinophilic Esophagitis Companies in the market include – Sanofi/Regeneron Pharmaceuticals, Dr. Falk Pharma GmbH, AstraZeneca and Amgen, Ellodi Pharmaceuticals, Aquestive Therapeutics, Atnahs Pharma (Pharmanovia), Jazz Pharmaceuticals, SK Biopharmaceutical,
The Key Atopic Dermatitis Companies in the market include – Kymab, BiomX, LEO Pharma, GlaxoSmithKline, Arjil Pharmaceuticals, SCM Lifescience, Sun Pharmaceutical Industries Limited, Brickell Biotech Inc,, AstraZeneca, Kyowa Kirin, UCB
The Key Alzheimer’s Disease Companies in the market include – Alpha Cognition, Biogen/Eisai, Eli Lilly, Otsuka Pharma/ Lundbeck, Suven Life Sciences, Roche, Annovis Bio, and others . The Alzheimer’s Disease
The Key Multiple Sclerosis Companies in the market include – Biogen, Immune Response BioPharma, ImCyse, Atara Biotherapeutics, Emerald Health Pharmaceuticals, Sanofi, RemeGen, Gossamer Bio, 4D Pharma, HuniLife Biotechnology, Anokion, GSK
(Las Vegas, Nevada, United States) – September 10, 2026: As per DelveInsight’s assessment, globally, Non-Hodgkin Lymphoma pipeline constitutes 180+ key companies continuously working towards developing 200 + Non-Hodgkin Lymphoma treatment
The Key Prostate Cancer Companies in the market include – Bayer, Johnson & Johnson Innovative Medicine (Janssen), Astellas Pharma, Pfizer, Janssen Research & Development/Tesaro, Sanofi, MacroGenics, Candel Therapeutics, Kangpu Biopharmaceuticals,
